SCHEMBL20921920

SCHEMBL20921920

CCCCOCCC(C)C(OC)c1c(C(=O)O)cnc2cc(C)nn12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.38
▸ MALT1 Q9UDY8 2/20 0.35
▸ BIRC3 Q13489 1/20 0.35
▸ NPC1 O15118 4/20 0.34
▸ RAB9A P51151 4/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ RARB P10826 3/20 0.33
▸ RARA P10276 2/20 0.33
▸ DPP4 P27487 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ DPP7 Q9UHL4 1/20 0.33
▸ RARG P13631 1/20 0.33
▸ LMNA P02545 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ KDM6B O15054 3/20 0.31
▸ KDM4A O75164 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18862726 0.80 CYP1A2 (0.49) CYP1A2MALT1BIRC3NPC1RAB9A
SCHEMBL22408846 0.80 CYP1A2 (0.49) CYP1A2MALT1BIRC3NPC1RAB9A
SCHEMBL17293094 0.76 CYP1A2 (0.51) CYP1A2MALT1BIRC3NPC1RAB9A
SCHEMBL17293093 0.76 CYP1A2 (0.51) CYP1A2MALT1BIRC3NPC1RAB9A
SCHEMBL20455857 0.73 CYP1A2 (0.56) CYP1A2MALT1BIRC3NPC1RAB9A
SCHEMBL22432051 0.72 CYP1A2 (0.45) CYP1A2MALT1BIRC3NPC1RAB9A
SCHEMBL18787694 0.70 MALT1 (0.45) MALT1BIRC3NPC1RAB9ASMN1; SMN2
SCHEMBL18862730 0.70 MALT1 (0.45) MALT1BIRC3NPC1RAB9ASMN1; SMN2
SCHEMBL20913179 0.70 MALT1 (0.45) MALT1BIRC3NPC1RAB9ASMN1; SMN2
SCHEMBL18839707 0.69 MALT1 (0.41) CYP1A2MALT1BIRC3NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3149001-B1 NOVEL PYRAZOLO PYRIMIDINE DERIVATIVES AND THEIR USE AS MALT1 INHIBITORS NOVARTIS AG (CH) 2019-04-24 — — EP disclosed
Send feedback